The Small Company Looking to Revolutionize The Trillion-Dollar Drug Sector
Cutting-edge life science company offers high upside cannabis medical product potential
Stay updated with breaking news from Research Advisor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cutting-edge life science company offers high upside cannabis medical product potential
Press release content from Globe Newswire. The AP news staff was not involved in its creation. DIACCURATE acquires BIOKINESIS to create a sole-in-class biotech player in oncology and ... DIACCURATEJanuary 12, 2021 GMT Dr. Dominique BRIDON leads the new entity DIACCURATE is now developing 3 programs in cancer and immunotherapy DIACCURATE will be initiating a first clinical trial by early 2022 Paris, France, January 12, 2021 By acquiring BIOKINESIS, a French biotech that develops the very first anticancer compound targeting the Golgi apparatus, DIACCURATE comforts its “sole-in-class” ther...